Personal TTFields device guided by imaging for brain tumor
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether using a personalized TTFields device—placed based on imaging—can help treat adults with glioblastoma (GBM) after surgery and radiation. It’s designed for specific GBM genetic types and may help deliver therapy more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 22 or older).
- You have confirmed glioblastoma (GBM), or a GBM type based on tumor genetics tests.
- You already had the most complete safe surgery possible, and then standard radiation (about 6 weeks) or a shorter radiation schedule (about 3 weeks).
- Your tumor matches one of the allowed genetic profiles (for example MGMT and/or IDH results).
- You must have blood, liver, and kidney function adequate for treatment and be able to take the maintenance medicine (temozolomide/TMZ) if required.
- You are willing to use TTFields and wear the device as instructed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This trial looks at how well Tumor Treating Fields (TTFields) therapy works for people with newly diagnosed glioblastoma. Researchers will study blood and tumor samples to find markers that might predict how well the treatment works.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
This trial tests whether wearing a device called Optune (which uses electric fields to slow cancer growth) before surgery helps people with glioblastoma. It is for patients who are fairly active and plan to have standard tumor removal and radiation therapy afterward.
This trial is testing a new approach for people with glioblastoma who have just completed standard radiation and chemotherapy. It aims to see if adding a special MRI scan can help guide treatment decisions and improve outcomes.
Hear when a new GBM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.